The polymorphisms of several genes, such as Patatin-like phospholipase domain-containing 3 (PNPLA3), leptin receptor (LEPR) and MTHFR, were reported to be involved in the genetic susceptibility to NAFLD [19–21]. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.